david quinn, md, discusses checkmate-214 investigating nivolumab ipilimumab in arcc patients
Published 4 years ago • 36 plays • Length 2:45
Download video MP4
Download video MP3
Similar videos
-
1:49
bradley mcgregor, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
-
2:01
michael atkins, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
-
1:39
david quinn, md, on best utilization of stereotactic radiation in the management of arcc patients
-
1:01
rana mckay, md, discusses checkmate214 investigating nivolumab ipilimumab in 1st line rcc patients
-
1:15
david quinn, md, describes if biomarkers help guide treatment in advanced renal cell carcinoma
-
1:39
david quinn, md, on impressions of the oral inhibitor study in renal cell carcinoma patients
-
1:01
david quinn, md, on how the measurement of ctc may or may not be changing the treatment of uc
-
1:53
david i. quinn, md, on which metastatic rcc patients should receive a tki as first-line therapy
-
1:06
dr. mckay discusses the checkmate-214 trial in rcc
-
1:17
dr. hammers on the checkmate-214 study for rcc
-
1:20
renal cell carcinoma: the emulsion and checkmate 214 trials
-
4:55
mutation testing
-
36:07
genitourinary cancers - dr. david quinn
-
1:18:37
miscellaneous cases 2
-
8:03
david i. quinn, md: bladder cancer 101
-
7:37
david i. quinn, md: what's new in bladder cancer advances?
-
28:11
managing advanced renal cell carcinoma - quinn
-
1:00
steven j. cohen, md, outlines the results of the checkmate 142 study in mcrc patients
-
1:18:45
the diagnostic dilemma
Clip.africa.com - Privacy-policy